Ipilimumab/nivolumab/vancomycinVarious toxicities and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1947卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35381-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：241 / 241

相关论文

共 50 条

[41] Tretinoin/vancomycinVarious toxicities: case report
Reactions Weekly, 2020, 1805 (1) : 290 - 290
[42] Daptomycin/vancomycinVarious toxicities: case report
Reactions Weekly, 2012, 1415 (1) : 19 - 19
[43] Cabozantinib/sorafenibVarious toxicities and off label use: case report
Reactions Weekly, 2022, 1894 (1) : 85 - 85
[44] MidostaurinVarious toxicities following an off label use: case report
Reactions Weekly, 2019, 1782 (1) : 221 - 221
[45] Citalopram/gliclazideVarious toxicities and off label use : case report
Reactions Weekly, 2023, 1969 (1) : 123 - 123
[46] PembrolizumabVarious toxicities secondary to off label use : case report
Reactions Weekly, 2021, 1862 (1) : 404 - 404
[47] OlanzapineVarious toxicities following off label use: case report
Reactions Weekly, 2021, 1883 (1) : 302 - 302
[48] PazopanibVarious toxicities following off label use: case report
Reactions Weekly, 2017, 1663 (1) : 243 - 243
[49] DaratumumabVarious toxicities and off-label use: case report
Reactions Weekly, 2023, 1965 (1) : 174 - 174
[50] Multiple drugsVarious toxicities and off label use: case report
Reactions Weekly, 2022, 1924 (1) : 340 - 340

← 1 2 3 4 5 →